Investor Alert: Warning about aggressive promotion of Revive Therapeutics

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Investor Alert: Warning about aggressive promotion of Revive Therapeutics

Canada NewsWire

VANCOUVER, April 6, 2020 /CNW/ - The British Columbia Securities Commission (BCSC) is warning the public to exercise extreme caution about aggressive promotion of companies with products or initiatives to detect, cure or treat COVID-19.

The BCSC is aware that Revive Therapeutics Inc. a B.C. reporting issuer, is currently being promoted in North America and Europe. The pharmaceutical company is based in Ontario and listed on the Canadian Securities Exchange.

Germany's Federal Financial Supervisory Authority has issued an investor alert about Revive, warning that buy recommendations are currently being made on a large scale in the form of market letters and e-mails. The promotions in Germany make aggressive claims about Revive's potential success in treating COVID-19 and the prospects of investors receiving large profits.

The BCSC reminds investors to exercise caution when considering aggressive promotions as a basis for investment decisions as these promotions may make false claims of large profits. At this time, there is no vaccine or any health product that is authorized to treat or protect against COVID-19.

The BCSC encourages anyone who is considering buying or selling an investment to do research or talk to their registered investment advisor to ensure it is an appropriate decision. For information on how to become better informed about investment products and services, please visit InvestRight at www.investright.org.

More information about the BCSC's response to the COVID-19 crisis is available here.

About the British Columbia Securities Commission (www.bcsc.bc.ca)  

The British Columbia Securities Commission is the independent provincial government agency responsible for regulating capital markets in British Columbia through the administration of the Securities Act. Our mission is to protect and promote the public interest by fostering:

  • A securities market that is fair and warrants public confidence
  • A dynamic and competitive securities industry that provides investment opportunities and access to capital

Learn how to protect yourself and become a more informed investor at www.investright.org

SOURCE British Columbia Securities Commission

Cision View original content: http://www.newswire.ca/en/releases/archive/April2020/06/c7244.html

Copyright CNW Group 2020

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).